ATLANTA, July 01, 2025 (GLOBE NEWSWIRE) — The Dr. Michael Lebow Scholarship for Future Doctors is now officially open for applications, inviting undergraduate students across the United States to compete for a one-time academic award designed to support and encourage future leaders in the healthcare field. This prestigious scholarship, created by esteemed vascular surgeon Dr. […]

Dr. Michael Lebow Launches Nationwide Scholarship Initiative to Support Aspiring Healthcare Professionals in the United States GlobeNewswire July 01, 2025 ATLANTA, July 01, 2025 (GLOBE NEWSWIRE) — The Dr. Michael Lebow Scholarship for Future Doctors is now officially open for applications, inviting undergraduate students across the United States to compete for a one-time academic award

Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative medicines in the field of immunotherapy, today announced the pricing of its underwritten public offering of $100 million of shares of its common stock. Nektar is selling 4,255,320 shares of common stock in the offering. The shares of common stock are

(NASDAQ:ABEO), CLEVELAND, July 01, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). On June 30, 2025, the Compensation Committee of Abeona's Board of Directors granted restricted stock

MADISON, CONN., July 01, 2025 (GLOBE NEWSWIRE) — Renewal by Andersen, which bills itself as “one of largest replacement window companies in the country,” is deceptively marketing its products as Made in USA in violation of the FTC's Made in USA Labeling Rule, according to an investigation by consumer advocacy organization truthinadvertising.org (TINA.org). The ad

KIGALI, Rwanda and SAN FRANCISCO and ZUG, Switzerland , July 01, 2025 (GLOBE NEWSWIRE) — Bio Usawa Biotechnology Ltd. (Bio Usawa) and Bioeq AG today announced a groundbreaking agreement that will bring a life-changing biosimilar medicine–ranibizumab, used to treat serious retinal diseases–within reach for millions across Sub-Saharan Africa. This partnership grants Bio Usawa exclusive rights

ePlus inc. (NASDAQ NGS: PLUS – news) today announced that it has closed on the sale of its U.S. financing business to Marlin Leasing Corporation (dba PEAC Solutions), a portfolio company of the Asset Value Funds sponsored and managed by leading global investment firm HPS Investment Partners, LLC. The signing was previously announced on June

Proxy Advisory Firms Recommend Against Giving Ortelius Control of the Company's Board Brookdale Urges Shareholders to Vote “FOR” ALL of Brookdale's Eight Highly Qualified Director Nominees on the BLUE Proxy Card Brookdale Senior Living Inc. (NYSE: BKD) (“Brookdale” or the “Company”) today announced that proxy advisory firm Glass, Lewis & Co., LLC (“Glass Lewis”) has

As an investment executive at U.S. Trust / Bank of America Private Bank, Trippe directly managed client assets in excess of $2 billion; he brings 40+ years of experience serving UHNW clients to Fidelis Capital. Fidelis Capitalannounced today that former U.S. Trust / Bank of America Private Bank investment executive Paul Trippe has joined the

Renewal by Andersen Reported for Making Deceptive Made in USA Claims TINA.org Files Complaint against Window Company with FTC GlobeNewswire July 01, 2025 MADISON, CONN., July 01, 2025 (GLOBE NEWSWIRE) — Renewal by Andersen, which bills itself as “one of largest replacement window companies in the country,” is deceptively marketing its products as Made in